Huadong Medicine (SHE:000963) posted first-half net profit attributable to shareholders of 1.70 billion yuan, or 0.9686 yuan per share, up 18% from 1.43 billion yuan, or 0.8190 yuan per share, in the same period the previous year.
Operating income went up 3% year over year to 20.97 billion yuan from 20.39 billion yuan, according to a Friday filing with the Shenzhen bourse.
The pharmaceutical company declared a cash dividend of 3.50 yuan per 10 shares.
Huadong Medicine shares rose 2% in recent trade.
Price (RMB): ¥28.33, Change: ¥+0.56, Percent Change: +2.02%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments